Status:
RECRUITING
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
Lead Sponsor:
University of California, San Diego
Collaborating Sponsors:
University of Nigeria Nsukka
Conditions:
HIV
Cervical Cancer
Eligibility:
FEMALE
25-64 years
Phase:
NA
Brief Summary
While there has been a significant increase in the uptake of antiretroviral therapy among women living with HIV (WLHIV) in many low- and-middle income countries (LMICs), the coverage of cervical cance...
Detailed Description
Nigeria has one of the largest HIV epidemics in the world with 1.8 million people living with HIV infection. With an estimated female population of 102 million and HIV prevalence of 1.6% among adult f...
Eligibility Criteria
Inclusion
- Women living with HIV
Exclusion
- \-
Key Trial Info
Start Date :
November 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2027
Estimated Enrollment :
2436 Patients enrolled
Trial Details
Trial ID
NCT06128304
Start Date
November 13 2023
End Date
August 31 2027
Last Update
December 10 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UC San Diego
La Jolla, California, United States, 92093
2
University of Nigeria, Nsukka
Enugu, Enugu State, Nigeria